¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024³â ´ëÇѳúÁ¹ÁßÇÐȸ Ãá°èÇмú´ëȸ : 2024-04-20

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024³â ´ëÇѳúÁ¹ÁßÇÐȸ Ãá°èÇмú´ëȸ : 2024-04-20
±³À°ÀÏÀÚ : 2024-04-20
±³À°Àå¼Ò : ·Ôµ¥È£ÅÚ Á¦ÁÖ

±³À°ÁÖÁ¦ : 2024³â ´ëÇѳúÁ¹ÁßÇÐȸ Ãá°èÇмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇѳúÁ¹ÁßÇÐȸ
´ã´çÀÚ : ±èÈñ¿µ
¿¬¶ôó : 0502-277-1919  

À̸ÞÀÏ : stroke@stroke.or.kr

±³À°Á¾·ù : ½Å°æ¿Ü°ú, ¿µ»óÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú

Âü¼®¿¹»óÀÎ : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : Á¦ÁÖƯº°ÀÚÄ¡µµ
±³À°½Ã°£ : 7 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 140,000¿ø  

ºñ°í Á¤È¸¿ø(»çÀüµî·Ï 50,000, ¿¬È¸ºñ+»çÀüµî·Ï 120,000¿ø, ÇöÀåµî·Ï 60,000¿ø)/ Á¤È¸¿ø Áß ÀüÀÓÀÇ, °øº¸ÀÇ, ±ºÀÇ°ü(»çÀüµî·Ï 30,000, ¿¬È¸ºñ+»çÀüµî·Ï 100,000¿ø, ÇöÀåµî·Ï 40,000¿ø)/ ÁØȸ¿ø, ÀϹÝȸ¿ø(»çÀüµî·Ï 30,000, ¿¬È¸ºñ+»çÀüµî·Ï 50,000¿ø, ÇöÀåµî·Ï 40,000¿ø)/ ºñȸ¿ø(»çÀüµî·Ï 110,000¿ø, ÇöÀåµî·Ï 120,000¿ø)/ ºñȸ¿ø Áß °£È£»ç(»çÀüµî·Ï 60,000¿ø, ÇöÀåµî·Ï 70,000¿ø)/ Á¤È¸¿ø Áß È¸ºñ¹Ì³³È¸¿ø(»çÀüµî·Ï 130,000¿ø, ÇöÀåµî·Ï 140,000¿ø)


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 20ÀÏ ·Ôµ¥È£ÅÚ Á¦ÁÖ 09:00~09:20 Cancer-related stroke À¯ÁØ»ó(¿¬¼¼ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 04¿ù 20ÀÏ ·Ôµ¥È£ÅÚ Á¦ÁÖ 09:20~09:40 Antiphospholipid antibody syndrome ¾ç¿íÁø(¼­¿ïÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 04¿ù 20ÀÏ ·Ôµ¥È£ÅÚ Á¦ÁÖ 09:40~10:00 Moyamoya disease Á¤Á¾¿ø(¼º±Õ°üÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 04¿ù 20ÀÏ ·Ôµ¥È£ÅÚ Á¦ÁÖ 10:00~10:20 Dissection ÇãÁسç(Áß¾ÓÀÇ´ë ½Å°æ°ú)

ÈÞ½Ä 04¿ù 20ÀÏ ·Ôµ¥È£ÅÚ Á¦ÁÖ 10:20~10:40 Break ()

±³À°½Ã°£ 04¿ù 20ÀÏ ·Ôµ¥È£ÅÚ Á¦ÁÖ 10:40~11:10 Blood pressure and cholesterol lowering for secondary stroke prevention Meng Lee(Chang Gung Memorial Hospital, Taiwan)

±³À°½Ã°£ 04¿ù 20ÀÏ ·Ôµ¥È£ÅÚ Á¦ÁÖ 11:10~11:40 Smoking cessation therapy ¼­È«°ü(±¹¸³¾Ï¼¾ÅÍ °¡Á¤ÀÇÇаú)

±³À°½Ã°£ 04¿ù 20ÀÏ ·Ôµ¥È£ÅÚ Á¦ÁÖ 11:40~12:20 Mechanical thrombectomy for large ischemic infarcts: The end of a journey? Raul G. Nogueira(Univ. of Pittsburgh, USA)

±âŸ 04¿ù 20ÀÏ ·Ôµ¥È£ÅÚ Á¦ÁÖ 12:20~12:40 General Assembly ()

±³À°½Ã°£ 04¿ù 20ÀÏ ·Ôµ¥È£ÅÚ Á¦ÁÖ 12:40~13:10 The role of cerebrolysin in the treatment of ischemic stroke ±èÄ¡°æ(°í·ÁÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 04¿ù 20ÀÏ ·Ôµ¥È£ÅÚ Á¦ÁÖ 13:10~13:40 Anticoagulation strategy in elderly patients with AF: Focusing on Edoxaban ±èÁØ¿±(¼­¿ïÀÇ´ë ½Å°æ°ú)

ÈÞ½Ä 04¿ù 20ÀÏ ·Ôµ¥È£ÅÚ Á¦ÁÖ 13:40~14:00 Break ()

±³À°½Ã°£ 04¿ù 20ÀÏ ·Ôµ¥È£ÅÚ Á¦ÁÖ 14:00~14:20 Novel anti-obesity drugs ¼ÕÀå¿ø(°¡Å縯ÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 04¿ù 20ÀÏ ·Ôµ¥È£ÅÚ Á¦ÁÖ 14:20~14:40 Updated strategies for dyslipidemia ÀåÁØ¿µ(¿ï»êÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 04¿ù 20ÀÏ ·Ôµ¥È£ÅÚ Á¦ÁÖ 14:40~15:00 Updated strategy for bone health ±è°æ¹Î(¿¬¼¼ÀÇ´ë ³»ºÐºñ³»°ú)

Åä·Ð 04¿ù 20ÀÏ ·Ôµ¥È£ÅÚ Á¦ÁÖ 15:00~16:00 Poster Presentation ()

±³À°½Ã°£ 04¿ù 20ÀÏ ·Ôµ¥È£ÅÚ Á¦ÁÖ 16:00~16:20 Novel AI models: Introduction and applications ¹Ú¼ºÈ£(ÀÎÁ¦ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 04¿ù 20ÀÏ ·Ôµ¥È£ÅÚ Á¦ÁÖ 16:20~16:40 AI models at the forefront in neuroimaging field Á¶È¯È£(ÀÎõ´ëÇб³)

±³À°½Ã°£ 04¿ù 20ÀÏ ·Ôµ¥È£ÅÚ Á¦ÁÖ 16:40~17:00 Digital twins transforming stroke patient care ³²È¿¼®(¿¬¼¼ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 04¿ù 20ÀÏ ·Ôµ¥È£ÅÚ Á¦ÁÖ 17:00~17:20 Pioneering hospital-based smart healthcare solutions À̹οì(ÇѸ²ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 04¿ù 20ÀÏ ·Ôµ¥È£ÅÚ Á¦ÁÖ 17:20~17:40 Digital therapeutics °­µ¿È­(¿ï»êÀÇ´ë ½Å°æ°ú)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024³â ´ëÇѳúÁ¹ÁßÇÐȸ Ãá°èÇмú´ëȸ : 2024-04-20""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѼÒÈ­±âÇÐȸ SIDDS 2024 In Conjunction with the Annual Meeting of the KSG (1ÀÏÂ÷) : 2024-04-20
´ÙÀ½±Û À§¾Ï ȯÀÚ »îÀÇ Áú ¿¬±¸È¸ 2024 Ãá°è Çмú´ëȸ : 2024-04-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
279 °­¿ø ÇѸ²´ëÇб³Ãáõ¼º½Éº´¿ø Á¦ 130ȸ ¼ÒÈ­±â¼¾ÅÍ ¿¬¼ö±³À° : 2018-09-19 0 734 2018-07-28
278 ¼­¿ï Çѱ¹ºÐÀÚ¼¼Æ÷»ý¹°ÇÐȸ Á¤±âÇмú´ëȸ : 2018-09-19 0 502 2018-07-28
277 ¼­¿ï ¼ÛÆı¸(4Â÷) °³¿øÀÇ ¿¬¼ö±³À°(¿äÅëȯÀÚ, °ñ´Ù°øÁõ) : 2018-09-18 0 506 2018-07-28
276 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø ¾È°úÁö¿ªÀÇ»ç Áý´ãȸ : 2018-09-18 0 519 2018-07-28
275 °æ±â Â÷ÀÇ°úÇдëÇб³ºÐ´çÂ÷º´¿ø ³ì³»Àå : 2018-09-18 0 658 2018-07-28
274 ´ë±¸ ´ëÇѽŰæ°úÇÐȸ ´ë°æÁöȸ - ´ë°æ½Å°æ°úÀÇ»çȸ °øµ¿ ½ÉÆ÷Áö¿ò : 2018-09-18 0 1,497 2018-07-28
273 ¼­¿ï Çѱ¹ºÐÀÚ¼¼Æ÷»ý¹°ÇÐȸ Á¤±âÇмú´ëȸ : 2018-09-18 0 619 2018-07-28
272 ¼­¿ï Çѱ¹ºÐÀÚ¼¼Æ÷»ý¹°ÇÐȸ Á¤±âÇмú´ëȸ : 2018-09-17 0 425 2018-07-28
271 °æ±â Á¦ 1ȸ ¾ÆÁִ뺴¿ø ½ÅÀå³»°ú ¿¬¼ö°­Á : 2018-09-16 0 2,093 2018-07-28
270 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Á¦53Â÷ ¾Ë·¹¸£±â ±³À°°­Á : 2018-09-16 0 568 2018-07-28
269 ¼­¿ï 2018³â Á¦3ȸ »ï¼º¼­¿ïº´¿ø ¿Ü°ú ½ÉÆ÷Áö¿ò : 2018-09-16 0 932 2018-07-28
268 ´ë±¸ 2018³âµµ ´ëÇÑÁ¤Çü¿Ü°úÀÇ»çȸ Çмú´ëȸ : 2018-09-16 0 821 2018-07-28
267 ¼­¿ï ½ÉÀå´ë»çÁõÈıº¿¬±¸È¸ 2018 Ãß°è½ÉÆ÷Áö¾ö : 2018-09-15 0 676 2018-07-28
266 ¼­¿ï °æÈñ´ëÇб³º´¿ø µ¿¹®Áý´ãȸ_°íȲÀ̺ñÀÎÈÄ°ú ¿¬±¸È¸ ¼¼¹Ì³ª : 2018-09-15 0 1,393 2018-07-28
265 ¼­¿ï 2018 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤ : °æ°è¼± ÀΰÝÀå¾Ö : 2018-09-15 0 1,170 2018-07-28
1361 | 1362 | 1363 | 1364 | 1365 | 1366 | 1367 | 1368 | 1369 | 1370
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷